Brief: FDA Receives 3 Reports Of Serious Injuries With Novum IQ LVP & Novum IQ SP, As Of July 21

Baxter International

15/08/2025 17:36

Aug 15 (Reuters) - FDA:

FDA: AWARE BAXTER ISSUED LETTER TO AFFECTED CUSTOMERS RECOMMENDING ALL NOVUM IQ LVP, NOVUM IQ SP BE CORRECTED PRIOR TO USE

FDA: RECEIVED THREE REPORTS OF SERIOUS INJURIES AND NO REPORTS OF DEATH ASSOCIATED WITH NOVUM IQ LVP AND NOVUM IQ SP, AS OF JULY 21

 ((Reuters.Briefs@thomsonreuters.com;))